Clinical trial
Phase III Study Comparing Irradiation at a Dose of 80 Gy to Irradiation at 70 Gy in Unfavorable Prostate Cancers Associated With Prolonged Hormonal Therapy
NCT00967863 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase III Study Comparing Irradiation at a Dose of 80 Gy to Irradiation at 70 Gy in Unfavorable Prostate Cancers Associated With Prolonged Hormonal Therapy
- Lead sponsor
- UNICANCER
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- October 31, 2008
- Completion date
- October 31, 2026
- Enrollment
- 500 (estimated)
- Sites
- 25
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer